| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.0M | — | +129.3% |
| Cost of Revenue | $517K | — | +11.1% |
| Gross Profit | $3.5M | — | +171.8% |
| R&D Expense | $514K | — | -14.6% |
| SG&A Expense | $1.7M | — | +45.4% |
| Operating Income | $1.1M | — | +1233.6% |
| Interest Expense | $3K | — | -75.4% |
| Net Income | $316K | — | -69.7% |
| EPS (Basic) | $0.06 | — | -81.8% |
| EPS (Diluted) | $0.06 | — | -81.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.9M | +17.3% | +457.8% |
| Current Assets | $9.1M | +19.5% | +233.5% |
| Total Assets | $13.9M | +16.0% | +128.9% |
| Current Liabilities | $3.9M | +16.1% | -15.7% |
| Total Liabilities | $5.3M | +21.3% | +14.6% |
| Stockholders' Equity | $7.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.6M | — | +440.5% |
| Capital Expenditures | $22K | — | — |
| Investing Cash Flow | -$650K | — | — |
| Financing Cash Flow | -$63K | — | +57.8% |
| Free Cash Flow | $1.6M | — | — |
| +987.4% |